UroLift ATC™ Advanced Tissue Control System

Easier to treat a wide spectrum of anatomies, including obstructive median lobes and lateral lobes

The UroLift ATC™ Advanced Tissue Control System delivers the same, proven implant through an enhanced delivery device tip that enables urologists to more easily treat BPH patients with challenging anatomies, including an obstructive median lobe and lateral lobes. The wings are designed to provide more tissue control which may reduce procedural manipulations.1  

1 Tissue Control Wings

  • Hold tissue during manipulation for enhanced control
  • Shaped to minimize view obstruction

2 Needle Location Marker

  • Laser-etched markings for targeting accuracy and predictable implant placement
  • Needle penetrates tissue in line with the markings

3 Atraumatic Design

  • Tissue control wings have rounded edges
  • Wings are constructed of flexible stainless steel material
The UroLift™ System achieves consistent results in patients with an obstructive median lobe.**
-55%, 13.5pt reduction IPSS at 12 months in MedLift Study2
"My experience with the UroLift ATC™ System has been overwhelmingly positive. The new design features of the UroLift ATC™ System make it easier for me to treat patients with complex anatomies, and especially increase my confidence in treating patients with an obstructive median lobe."
Dr. Steven Gange+

Illustrated Cystoscopic View

Wings are designed to hold tissue for enhanced control during the procedure.

Treat the Median Lobe With Confidence

Results may vary
References

1.  Data on file at Teleflex
2. Rukstalis et. al, Prostate Cancer and Prostatic Diseases 2018 MedLift Study

 

 

*The UroLift Advanced Tissue Control (ATC) System is indicated to treat patients with prostate sizes up to 100cc
**Demonstrated with UL400 device in MedLift Study
+Dr. Steven Gange is an employee of Teleflex
MAC12001-05 Rev A